[Pseudohypoparathyroidism]

Przegl Lek. 2000;57(1):45-7.
[Article in Polish]

Abstract

The article presents data concerning pseudohypoparathyroidism (PH TP). It is an unusual disease, which is characterized by the resistance of bones and kidney to PTH, followed by hypocalcaemia, hyperphospha-taemia, glandulary hypertrophy and hypersecretion of PTH. Patients with PTHT clinically manifest tetany seizures, soft tissue calcifications and many congenital malformations. The disease has a genetic etiology, it is connected with chromosome X and more often found in women. Clinical symptoms may be different and depend on genetic defect or its selectivity with reference to the tissues. At present we can distinguish three types of PHPT and pseudo-pseudo-HPT. The disease usually appears in the infancy. Early diagnosis and vitamin D3 or calcium treatment seem to be the most important for patient's condition. Too late treatment threatens with brain calcification followed by neurological defects and mental retardation. The long-lasting effect of PTH in bones can lead to their destruction, if bone receptors are completely sensitive.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Calcium / therapeutic use
  • Cholecalciferol / therapeutic use
  • Female
  • Humans
  • Infant
  • Male
  • Pseudohypoparathyroidism / diagnosis*
  • Pseudohypoparathyroidism / epidemiology
  • Pseudohypoparathyroidism / genetics
  • Pseudohypoparathyroidism / therapy*
  • Sex Distribution
  • Sex Factors
  • X Chromosome*

Substances

  • Cholecalciferol
  • Calcium